People

Ehren Halse is a Partner in King & Spalding’s Special Matters/Government Investigations Practice Group in San Francisco, CA. His practice focuses primarily on white-collar criminal litigation and corporate internal investigations, including defending individuals and companies in investigations by the Department of Justice, the Securities and Exchange Commission, Congress, the Department of the Treasury, the Food and Drug Administration, the Department of Health and Human Services Office of the Inspector General, numerous State Attorneys General and other state regulatory agencies.

In addition, he has conducted various internal investigations relating to financial fraud and government enforcement, and has helped clients to develop comprehensive compliance and training programs. Recently, his practice has focused on substantive legal areas such as the Foreign Corrupt Practices Act (“FCPA”) and anti-corruption/anti-bribery compliance, financial institutions fraud, FinTech and cryptocurrency/virtual asset regulation, U.S. economic sanctions and money laundering, cybersecurity and data privacy regulatory compliance and incident response, drug and medical device enforcement matters (e.g., healthcare fraud, anti-kickback, "off-label" promotion, and the False Claims Act), as well as e-discovery management and the attorney-client privilege and work product doctrine. He has a long history of pro bono work, including significant experience representing disabled Iraq and Afghanistan combat veterans in their disability claims process.

Publications

  • “Courts Diverge on the Reach of Personal Jurisdiction in FCPA Cases against Foreign Defendants,” Financial Fraud Law Report, Gary Grindler, Russ Ryan and Ehren Halse (April 2013).
  • “FCPA Demands Close Eye On Third Parties,” The Compliance Reporter’s ‘Adopting Best Practice In Compliance’, Zachary Harmon and Ehren Halse (September 1, 2010).
  •  “Recent Trends in FCPA Enforcement: Third-Party Agents,” Bloomberg Law Reports, Zachary Harmon and Ehren Halse (August 1, 2010).
Full Bio

Credentials

J.D., Georgetown University

B.A., Georgetown University

California

District of Columbia

Maryland

Co-Recipient of a 2011 Burton Award for Legal Achievement for, “Recent Trends in FCPA Enforcement: Third-Party Agents", which was published by Bloomberg Law Reports (July 30, 2010).

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

King & Spalding Pro Bono Service Award 2006 - 2013

Icon close

Close

Recognition

Co-Recipient of a 2011 Burton Award for Legal Achievement for, “Recent Trends in FCPA Enforcement: Third-Party Agents", which was published by Bloomberg Law Reports (July 30, 2010).

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

King & Spalding Pro Bono Service Award 2006 - 2013

Matters

Representing international corporations in internal compliance reviews and criminal and civil investigations by the DOJ and SEC, regarding whether marketing, sales and business practices in Africa, Asia, the Middle East, South America and Europe implicated the Foreign Corrupt Practices Act.

Represented a medical device manufacturer in a market-wide criminal and civil inquiry into allegations of violations of the Foreign Corrupt Practices Act.

Assisted international pharmaceutical companies with internal reviews of anti-kickback compliance protocols.

See more
Icon close

Close

Matters

Representing international corporations in internal compliance reviews and criminal and civil investigations by the DOJ and SEC, regarding whether marketing, sales and business practices in Africa, Asia, the Middle East, South America and Europe implicated the Foreign Corrupt Practices Act.

Represented a medical device manufacturer in a market-wide criminal and civil inquiry into allegations of violations of the Foreign Corrupt Practices Act.

Assisted international pharmaceutical companies with internal reviews of anti-kickback compliance protocols.

Represented a private Medicare and Medicaid provider in criminal and civil investigations by the Tampa U.S. Attorney’s Office, DOJ, DHHS-OIG, qui tam Relators, and States’ Attorneys General into alleged health care and political contributions fraud.

Represented multiple drug companies in criminal and civil investigations by the Boston U.S. Attorney’s Offices, DOJ, and DHHS-OIG, as well as internal compliance reviews regarding alleged “off-label” promotion and other allegedly fraudulent sales, marketing and development activities.

Represented an individual investigated by the Senate Permanent Subcommittee for Investigations for alleged participation in an off-shore tax shelter.  No charges were pursued against the client.

Represented the former General Counsel of a Silicon Valley tech company investigated by the U.S. Attorney’s office for the Northern District of California and the SEC for involvement in an alleged scheme of stock options backdating.  No charges were pursued against the client.

Represented domestic and international banks regarding alleged tax shelter schemes, price-fixing, bribery and competitor collusion (internal compliance reviews and criminal, tax and civil investigations by the SEC, IRS and DOJ).

Represented various companies in criminal and civil antitrust investigations led by the DOJ and SEC regarding alleged price-fixing, bid-rigging and market collusion.

Seven years of pro bono representation (over 45 clients) of disabled Iraq and Afghanistan War veterans regarding disability benefits claims with every branch of the military and the Department of Veteran’s Affairs.

Representing a leading virtual healthcare technology company concerning domestic and international data security and privacy regulatory compliance.

Representing companies in the FinTech industry with respect to economic sanctions compliance, including conducting internal investigations, OFAC subpoena response, and helping to design effective compliance programs.

Secured successful declination to prosecute on behalf of a Special Board Committee of an Indonesian-based energy group in an investigation by the DOJ into anticorruption allegations of payments made to foreign government officials.

Representing a publicly-traded pharmaceutical client concerning numerous DOJ and State Attorneys General investigations into the company’s past promotion of opioids.

Defending a leading financial institution in a DOJ investigation concerning the origination and sale of residential mortgage-backed securities, including matters involving the Presidential RMBS Task Force.

Matters

Representing international corporations in internal compliance reviews and criminal and civil investigations by the DOJ and SEC, regarding whether marketing, sales and business practices in Africa, Asia, the Middle East, South America and Europe implicated the Foreign Corrupt Practices Act.

Represented a medical device manufacturer in a market-wide criminal and civil inquiry into allegations of violations of the Foreign Corrupt Practices Act.

Assisted international pharmaceutical companies with internal reviews of anti-kickback compliance protocols.

See more
Icon close

Close

Matters

Representing international corporations in internal compliance reviews and criminal and civil investigations by the DOJ and SEC, regarding whether marketing, sales and business practices in Africa, Asia, the Middle East, South America and Europe implicated the Foreign Corrupt Practices Act.

Represented a medical device manufacturer in a market-wide criminal and civil inquiry into allegations of violations of the Foreign Corrupt Practices Act.

Assisted international pharmaceutical companies with internal reviews of anti-kickback compliance protocols.

Represented a private Medicare and Medicaid provider in criminal and civil investigations by the Tampa U.S. Attorney’s Office, DOJ, DHHS-OIG, qui tam Relators, and States’ Attorneys General into alleged health care and political contributions fraud.

Represented multiple drug companies in criminal and civil investigations by the Boston U.S. Attorney’s Offices, DOJ, and DHHS-OIG, as well as internal compliance reviews regarding alleged “off-label” promotion and other allegedly fraudulent sales, marketing and development activities.

Represented an individual investigated by the Senate Permanent Subcommittee for Investigations for alleged participation in an off-shore tax shelter.  No charges were pursued against the client.

Represented the former General Counsel of a Silicon Valley tech company investigated by the U.S. Attorney’s office for the Northern District of California and the SEC for involvement in an alleged scheme of stock options backdating.  No charges were pursued against the client.

Represented domestic and international banks regarding alleged tax shelter schemes, price-fixing, bribery and competitor collusion (internal compliance reviews and criminal, tax and civil investigations by the SEC, IRS and DOJ).

Represented various companies in criminal and civil antitrust investigations led by the DOJ and SEC regarding alleged price-fixing, bid-rigging and market collusion.

Seven years of pro bono representation (over 45 clients) of disabled Iraq and Afghanistan War veterans regarding disability benefits claims with every branch of the military and the Department of Veteran’s Affairs.

Representing a leading virtual healthcare technology company concerning domestic and international data security and privacy regulatory compliance.

Representing companies in the FinTech industry with respect to economic sanctions compliance, including conducting internal investigations, OFAC subpoena response, and helping to design effective compliance programs.

Secured successful declination to prosecute on behalf of a Special Board Committee of an Indonesian-based energy group in an investigation by the DOJ into anticorruption allegations of payments made to foreign government officials.

Representing a publicly-traded pharmaceutical client concerning numerous DOJ and State Attorneys General investigations into the company’s past promotion of opioids.

Defending a leading financial institution in a DOJ investigation concerning the origination and sale of residential mortgage-backed securities, including matters involving the Presidential RMBS Task Force.

Credentials

J.D., Georgetown University

B.A., Georgetown University

California

District of Columbia

Maryland

Co-Recipient of a 2011 Burton Award for Legal Achievement for, “Recent Trends in FCPA Enforcement: Third-Party Agents", which was published by Bloomberg Law Reports (July 30, 2010).

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

King & Spalding Pro Bono Service Award 2006 - 2013

Icon close

Close

Recognition

Co-Recipient of a 2011 Burton Award for Legal Achievement for, “Recent Trends in FCPA Enforcement: Third-Party Agents", which was published by Bloomberg Law Reports (July 30, 2010).

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

National Law Journal/Legal Times 2009 “Champion” award for pro bono efforts on behalf of disabled veterans

King & Spalding Pro Bono Service Award 2006 - 2013